Zelnorm Pulled From Shelves

A constipation medicine is being pulled off the shelves after it was linked to serious ailments, including heart attack and stroke.

Novartis is withdrawing the drug Zelnorm at the request of the Food and Drug Administration.

The drug is typically prescribed for women with irritable bowel syndrome to people under 65 with chronic constipation.

Doctors who prescribe Zelnorm are advised by the FDA  to transition their patients to other therapies.